These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11209138)

  • 21. Foscarnet-induced hypercalcaemia in AIDS.
    Gayet S; Ville E; Durand JM; Mars ME; Morange S; Kaplanski G; Gallais H; Soubeyrand J
    AIDS; 1997 Jul; 11(8):1068-70. PubMed ID: 9223751
    [No Abstract]   [Full Text] [Related]  

  • 22. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
    Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
    Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
    Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR
    AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441
    [No Abstract]   [Full Text] [Related]  

  • 24. Reversible cardiac dysfunction associated with foscarnet therapy for cytomegalovirus esophagitis in an AIDS patient.
    Brown DL; Sather S; Cheitlin MD
    Am Heart J; 1993 May; 125(5 Pt 1):1439-41. PubMed ID: 8386905
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypocalcemia in a patient with the acquired immunodeficiency syndrome treated only with foscarnet].
    Kindelan JM; García-Lázaro M; García-Herola A; Jurado R
    Med Clin (Barc); 1994 Oct; 103(14):559. PubMed ID: 7799675
    [No Abstract]   [Full Text] [Related]  

  • 26. Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy.
    Leporrier J; Etienne M; Chapuzet C; Peytavin G; Bord S; Borsa-Lebas F; Caron F; Plantier JC; Mourez T
    J Clin Virol; 2014 Aug; 60(4):428-30. PubMed ID: 24932736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy.
    Rajendran PM; Dolev JC; Heaphy MR; Maurer T
    Arch Dermatol; 2005 Oct; 141(10):1227-31. PubMed ID: 16230559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyradiculopathy due to cytomegalovirus infection: report of a case in which an AIDS patient responded to foscarnet therapy.
    Domingo P; Puig M; Iranzo A; Lopez-Contreras J; Ris J
    Clin Infect Dis; 1994 Jun; 18(6):1019-21. PubMed ID: 8086536
    [No Abstract]   [Full Text] [Related]  

  • 29. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
    Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
    J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytomegalovirus pneumonia in patients with AIDS treated foscarnet. Our experience].
    Terra L; Pellicanò S; Calzone R; Mandica D; Milano M
    Minerva Med; 1997 Oct; 88(10):411-3. PubMed ID: 9417536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foscarnet activity on human immunodeficiency virus type 1 in the central nervous system.
    Delforge ML; Farber CM; De Leener F; Caroyer JM; Liesnard C; Van Vooren JP
    Clin Infect Dis; 1999 Apr; 28(4):931. PubMed ID: 10825078
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients.
    Morfeldt L; Torssander J
    Scand J Infect Dis; 1994; 26(6):749-52. PubMed ID: 7747100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dermatologic aspects of HIV infections].
    Alessi E; Cusini M; Zerboni R
    G Ital Dermatol Venereol; 1988 Sep; 123(9):435-42. PubMed ID: 2977378
    [No Abstract]   [Full Text] [Related]  

  • 34. Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients.
    Charpentier C; Laureillard D; Sodqi M; Si-Mohamed A; Karmochkine M; Bélec L; Weiss L; Piketty C
    J Clin Virol; 2008 Oct; 43(2):212-5. PubMed ID: 18760662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Herpes zoster during foscarnet treatment in an AIDS patient].
    Ricart Olmos C; López Aldeguer J; Marino Blanes Juliá F; Sinelni E
    Med Clin (Barc); 1993 Oct; 101(12):477. PubMed ID: 8231374
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in treatment for cytomegalovirus retinitis.
    Bowers M
    BETA; 1995 Sep; ():13-5. PubMed ID: 11362885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of new transmissible herpesvirus suggests additional therapeutic approaches for KS.
    Oncology (Williston Park); 1996 Mar; 10(3):423-4. PubMed ID: 8820457
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of crystals in kidneys of AIDS patients treated with foscarnet.
    Maurice-Estepa L; Daudon M; Katlama C; Jouanneau C; Sazdovitch V; Lacour B; Beaufils H
    Am J Kidney Dis; 1998 Sep; 32(3):392-400. PubMed ID: 9740154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AIDS-related Kaposi sarcoma trial is under way.
    AIDS Read; 2001 Jan; 11(1):28. PubMed ID: 11215084
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurologic sequelae associated with foscarnet therapy.
    Lor E; Liu YQ
    Ann Pharmacother; 1994 Sep; 28(9):1035-7. PubMed ID: 7803878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.